New therapeutic approaches to Crohn's disease
- PMID: 10833215
- DOI: 10.1056/NEJM200006013422210
New therapeutic approaches to Crohn's disease
Comment on
-
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.N Engl J Med. 2000 Jun 1;342(22):1627-32. doi: 10.1056/NEJM200006013422202. N Engl J Med. 2000. PMID: 10833208 Clinical Trial.
-
A preliminary study of growth hormone therapy for Crohn's disease.N Engl J Med. 2000 Jun 1;342(22):1633-7. doi: 10.1056/NEJM200006013422203. N Engl J Med. 2000. PMID: 10833209 Clinical Trial.
Similar articles
-
Controlling Crohn's disease.Health News. 2000 Jul;6(7):8. Health News. 2000. PMID: 10932651 No abstract available.
-
[A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators].Gastroenterol Clin Biol. 2000 Dec;24(12):1243-4. Gastroenterol Clin Biol. 2000. PMID: 11277090 French. No abstract available.
-
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.N Engl J Med. 2000 Jun 1;342(22):1627-32. doi: 10.1056/NEJM200006013422202. N Engl J Med. 2000. PMID: 10833208 Clinical Trial.
-
[Is Crohn's disease an indication for growth hormone treatment?].Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006;12(3):237-40. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006. PMID: 17020663 Review. Polish.
-
Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission.Aliment Pharmacol Ther. 2007 Oct 1;26(7):987-1003. doi: 10.1111/j.1365-2036.2007.03455.x. Aliment Pharmacol Ther. 2007. PMID: 17877506 Review.
Cited by
-
Pharmacokinetic considerations in the treatment of inflammatory bowel disease.Clin Pharmacokinet. 2001;40(10):723-51. doi: 10.2165/00003088-200140100-00003. Clin Pharmacokinet. 2001. PMID: 11707060 Review.
-
Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease.PLoS One. 2012;7(11):e49138. doi: 10.1371/journal.pone.0049138. Epub 2012 Nov 28. PLoS One. 2012. PMID: 23209564 Free PMC article.
-
Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats.Clin Diagn Lab Immunol. 2004 May;11(3):581-7. doi: 10.1128/CDLI.11.3.581-587.2004. Clin Diagn Lab Immunol. 2004. PMID: 15138186 Free PMC article.
-
Evolving medical therapies for Crohn's disease.Curr Gastroenterol Rep. 2001 Dec;3(6):471-6. doi: 10.1007/s11894-001-0067-7. Curr Gastroenterol Rep. 2001. PMID: 11696284 Review.
-
Binding and transfer of human immunodeficiency virus by DC-SIGN+ cells in human rectal mucosa.J Virol. 2005 May;79(9):5762-73. doi: 10.1128/JVI.79.9.5762-5773.2005. J Virol. 2005. PMID: 15827191 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical